Literature DB >> 33227629

Successful Treatment of Pediatric FIRES With Anakinra.

Jennifer H Yang1, Shilpa Nataraj2, Shifteh Sattar3.   

Abstract

Keywords:  Anakinra; Epilepsy; FIRES; Febrile illness-related epilepsy syndrome; Refractory epilepsy

Year:  2020        PMID： 33227629     DOI： 10.1016/j.pediatrneurol.2020.10.009

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN： 0887-8994            Impact factor:   3.372


× No keyword cloud information.
  4 in total

1.  Fighting autoinflammation in FIRES: The role of interleukins and early immunomodulation.

Authors:  Marco Perulli; Gianpaolo Cicala; Ida Turrini; Elisa Musto; Michela Quintiliani; Maria Luigia Gambardella; Silvia Maria Pulitanò; Sarah Bompard; Susanna Staccioli; Laura Carmillo; Gabriele Di Sante; Francesco Ria; Chiara Veredice; Ilaria Contaldo; Domenica Battaglia
Journal:  Epilepsy Behav Rep       Date:  2022-02-22

2.  Targeting Inflammatory Mediators in Epilepsy: A Systematic Review of Its Molecular Basis and Clinical Applications.

Authors:  Giorgio Costagliola; Greta Depietri; Alexandre Michev; Antonella Riva; Thomas Foiadelli; Salvatore Savasta; Alice Bonuccelli; Diego Peroni; Rita Consolini; Gian Luigi Marseglia; Alessandro Orsini; Pasquale Striano
Journal:  Front Neurol       Date:  2022-03-11       Impact factor: 4.003

3.  Hypothesis: Febrile infection-related epilepsy syndrome is a microglial NLRP3 inflammasome/IL-1 axis-driven autoinflammatory syndrome.

Authors:  Wei-Sheng Lin; Ting-Rong Hsu
Journal:  Clin Transl Immunology       Date:  2021-06-14

Review 4.  Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy.

Authors:  Gaku Yamanaka; Yu Ishida; Kanako Kanou; Shinji Suzuki; Yusuke Watanabe; Tomoko Takamatsu; Shinichiro Morichi; Soken Go; Shingo Oana; Takashi Yamazaki; Hisashi Kawashima
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.